N/A
N=122
Strength for U in Relationship Empowerment
IPV · Perinatal · Mental Health
Bottom Line
View on ClinicalTrials.gov: NCT04218864 ↗Enrolled (actual)
122
Serious AEs
33.6%
Results posted
Aug 2025
Primary outcome: Primary: Composite Abuse Scale (CAS) — 29.13; 27.01; 10.54; 10.02 units on a scale — p=>0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Strength for U in Relationship Empowerment (SURE) (Behavioral); Attention, time, and information matched control (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Women and Infants Hospital of Rhode Island
- Primary completion
- Feb 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Composite Abuse Scale (CAS) |
29.13; 27.01; 10.54; 10.02; 9.69; 8.27 | >0.05 |
| SECONDARY The Positive Affect and Well-being Scale (PAW) |
29.39; 29.95; 31.68; 32.05; 33.21; 31.4 | >0.05 |
| SECONDARY Perceived Emotional Support (PES) |
14.61; 14.89; 15.41; 15.32; 15.75; 14.77 | >0.05 |
Summary
The objective of this study is to test whether the innovative intervention, "Strength for U in Relationship Empowerment" (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.
Eligibility Criteria
Inclusion Criteria
- Pregnant women
- Women who have had a baby in the last 12 months
- Between the ages of 18-45 years old
- Have reported partner abuse within the last year as measured by the Woman Abuse Screening Tool (WAST)
- Have sought mental health treatment
Exclusion Criteria
- Cannot provide informed consent
- Unable to understand English
- No access to the internet or a device with internet access
- Discomfort with internet use
- No privacy to view a 40-minute online intervention
- Screen positive for risk of intimate partner violence that involves severe injury or homicide
- Screen positive for risk of spyware/stalkerware
- At one of the two research site, study recruit is unwilling to meet for in-person study visits (if criteria 3-8 are met)
Data sourced from ClinicalTrials.gov (NCT04218864). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.